We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$46.2B
AUM Growth
+$1.83B
Cap. Flow
-$543M
Cap. Flow %
-1.17%
Top 10 Hldgs %
24.86%
Holding
1,809
New
24
Increased
1,140
Reduced
325
Closed
37

Sector Composition

Rank Sector Weight
1 Technology 22.89%
2 Healthcare 18.49%
3 Financials 11.85%
4 Consumer Discretionary 9.1%
5 Industrials 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBIO
1751
DELISTED
Generation Bio
GBIO
$132K ﹤0.01%
3,064
+1,540
+101% +$74.5K
BCEL
1752
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$120K ﹤0.01%
105,283
FOX icon
1753
Fox Class B
FOX
$21.3B
$109K ﹤0.01%
3,467
+1,194
+53% +$37.4K
OLPX
1754
DELISTED
Olaplex Holdings
OLPX
$107K ﹤0.01%
25,167
+10,062
+67% +$53.6K
VIRX
1755
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$101K ﹤0.01%
63,406
NKTX icon
1756
Nkarta
NKTX
$162M
$100K ﹤0.01%
28,265
-67,851
-71% -$322K
INAB icon
1757
IN8bio
INAB
$11.4M
$91K ﹤0.01%
2,334
RBCAA icon
1758
Republic Bancorp
RBCAA
$1.9B
$83.2K ﹤0.01%
1,960
+500
+34% +$21.6K
ATYR
1759
aTyr Pharma
ATYR
$48M
$79.6K ﹤0.01%
37,884
RIVN icon
1760
Rivian
RIVN
$23.9B
$78.2K ﹤0.01%
5,050
+450
+10% +$7.6K
LCID icon
1761
Lucid Motors
LCID
$2.54B
$73.2K ﹤0.01%
910
SERA icon
1762
Sera Prognostics
SERA
$80.3M
$69.4K ﹤0.01%
18,108
OZON
1763
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$67.1K ﹤0.01%
2,750
LBTYA icon
1764
Liberty Global Class A
LBTYA
$3.35B
$63.4K ﹤0.01%
3,250
CDAK
1765
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$44.1K ﹤0.01%
252,782
XPER icon
1766
Xperi
XPER
$367M
$40.1K ﹤0.01%
3,668
AMWL icon
1767
American Well
AMWL
$185M
$32.1K ﹤0.01%
681
+21
+3% +$1.35K
KRON
1768
DELISTED
Kronos Bio
KRON
$23.6K ﹤0.01%
16,150
-325,653
-95% -$624K
SYBX
1769
DELISTED
Synlogic
SYBX
$20.9K ﹤0.01%
2,207
XLB icon
1770
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
$5.97K ﹤0.01%
148
-14
-9% -$567
DNA.WS
1771
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$2.9K ﹤0.01%
16,100
APP icon
1772
Applovin
APP
$139B
-27,458
Closed -$289K
BRZE icon
1773
Braze
BRZE
$2.65B
-11,038
Closed -$301K
COGT icon
1774
Cogent Biosciences
COGT
$6.91B
-51,138
Closed -$591K
CRBU icon
1775
Caribou Biosciences
CRBU
$158M
-76,657
Closed -$481K

Similar funds

Ensign Peak Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Ensign Peak Advisors held 1,809 positions worth $46.2B, up 4.1% from $44.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 3.4%. Ensign Peak Advisors opened 24 new positions and exited 37, leaving the 1,809-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q1 2023 buy was State Street Financial Select Sector SPDR ETF: 1,117,296 shares worth $35.9M.
  • Ensign Peak Advisors added most to Eli Lilly in Q1 2023, an estimated $98M increase.
  • Ensign Peak Advisors's biggest Q1 2023 reduction was First Republic Bank, cutting an estimated $198M.
  • Ensign Peak Advisors fully exited iShares Russell 2000 ETF in Q1 2023, selling an estimated $179M.
  • Ensign Peak Advisors's ten largest holdings make up 25% of its $46.2B portfolio in Q1 2023.
  • Ensign Peak Advisors opened 24 new positions and closed 37 in Q1 2023.
  • Ensign Peak Advisors's portfolio value rose 4.1% quarter-over-quarter to $46.2B.

Based on Ensign Peak Advisors's 13F filing for Q1 2023, filed 15 May 2023.